By Dr. Michelle Liu, Abbvie Crystallization processes in pharmaceutical development are designed to reliably produce a solid form with a Pareto-optimal profile of multiple properties including stability, solubility,...
Michelle is a computational chemist in the Molecular Profiling and Drug Delivery at AbbVie, supporting drug development programs across the discovery–development continuum. Her work and research interests include prediction...
By Dr. Guanghui Zhu, Takeda Pharmaceuticals Particle engineering has emerged as a critical frontier in pharmaceutical process development, enabling control over drug formulation and delivery. By manipulating the size,...
Guanghui Zhu holds a PhD degree in Chemical Engineering from Georgia Tech. He currently works as a Senior Staff Engineer in the Synthetic Molecule Process Development group in Takeda,...
Stephanie received her Ph.D. in Chemistry from the University of Windsor (Ontario, Canada) with Prof. Charles L.B. Macdonald in 2017. There, she specialized in crystallography and organophosphorus transformations. After...
By Dr. David J. Lamberto, Merck The crystallization of an active pharmaceutical ingredient (API) from ethanol and water exhibited non-typical behavior relative to the formation of the desired three-dimensional...
David J. Lamberto received his bachelor’s degree in chemical engineering from the University of Arizona before pursuing his Ph.D. and master’s degrees in chemical engineering from Rutgers University. His...
Richard is the Managing Director of Blaze Metrics, a company that designs, develops, and assists their customers to implement and apply cutting edge In-Process Microscopy, Spectroscopy, & Analytics from...
Dr. Yuriy Abramov is an industrial computational scientist with over 18 years experience at Pfizer Inc. Currently he holds a position of an Executive Director of computational chemistry and...
